Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Market Report 2021" report has been added to ResearchAndMarkets.com's offering. The report has hundreds of...
-
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "North America HPV Testing and Pap Test Market By Type, By Application, By Product, By End Use, By Country, Growth Potential, Industry Analysis Report...
-
Dublin, June 29, 2021 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics - Strategies and Trends. COVID-19 Adjusted Forecasts by Application by Channel by Country. With Market Analysis,...
-
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "HPV Testing and Pap Test Market Size, Share & Trends Analysis Report by Test Type, by Application (Cervical Cancer Screening, Vaginal Cancer...
-
Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
-
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics - Strategies and Trends, Forecasts By Application, By Channel, By Country - With Market Analysis, Executive...
-
Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics - Strategies and Trends. COVID-19 Adjusted Forecasts by Application by Channel by Country. With Market Analysis,...
-
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics - Strategies and Trends, Forecasts By Application, By Channel, By Country - With Market Analysis, Executive...
-
PARIS and TOULOUSE, France, June 15, 2016 (GLOBE NEWSWIRE) -- Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative...
-
PARIS and TOULOUSE, France, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative...